Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2002

01-12-2002

Urinary estrogen metabolites and prostate cancer: a case–control study in the United States

Authors: Paola Muti, Kim Westerlind, Tiejian Wu, Thomas Grimaldi, John De Berry III, Holger Schünemann, Jo L. Freudenheim, Helyn Hill, Giuseppe Carruba, Leon Bradlow

Published in: Cancer Causes & Control | Issue 10/2002

Login to get access
Metadata
Title
Urinary estrogen metabolites and prostate cancer: a case–control study in the United States
Authors
Paola Muti
Kim Westerlind
Tiejian Wu
Thomas Grimaldi
John De Berry III
Holger Schünemann
Jo L. Freudenheim
Helyn Hill
Giuseppe Carruba
Leon Bradlow
Publication date
01-12-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 10/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1021986811425

Other articles of this Issue 10/2002

Cancer Causes & Control 10/2002 Go to the issue

OriginalPaper

Postmenopausal breast cancer is associated with high intakes of ω6 fatty acids (Sweden)

OriginalPaper

Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States)

Authors Index

Author index to Volume 13

OriginalPaper

Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States

OriginalPaper

Using hierarchical spatial models for cancer control planning in Minnesota (United States)

OriginalPaper

Toenail selenium concentration and lung cancer in male smokers (Finland)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits